Omobolaji Samuel Ajayi

Calprotectin as a Possible Biomarker in Various Lung Diseases

Maryam Abbas, Olumide Ijishakin, Shwetha Gopal, Iqra Saeed, Shilpa Arcot, Chidera Emmanuel Okezie, Gift Joanna Agbo, Victor Chiedozie Ezeamii, Omobolaji Samuel Ajayi, Ngozi Amanze, Sadam Alzaki, Tambi Isaac, Husna Shahnoor, Efe Okunzuwa & Amy Alfy · Journal of Advances in Medicine and Medical Research · 2023

Calprotectin (CLP) comprises two calcium-binding proteins from the S-100 protein family, S100A8 and S100A9. CLP involves various cellular processes in lung health and disease, including anti-microbial functions, pro- and anti-tumor properties, angiogenesis, DNA damage response, a...

Open access Research Article 10.9734/jammr/2023/v35i225265

Risk Factors, Preventive Measures, and Management of Monkeypox: A Systematic Review

Adedamola Sherif Agboola, Ayesha Taqi, Mohammed Aljunaid Alamin Alsheikh, Tania M. Cobena Bravo, Sadam Abualbshr Mohammed Alzaki, Oluwatobi Atiba, Macleans Anosike, Promise Osorochukwu Odumodu, George Paul Komolafe, Amarachi Valerie Duru, Olubusola Seun Oluwaseun, Omobolaji Samuel Ajayi, Abiola Yetunde Oyesile, Eman Alamin & Olasumbo Elizabeth Fagbenle · Journal of Advances in Medicine and Medical Research · 2025

Background: Mpox, formerly known as monkeypox, is an emerging viral disease caused by the mpox virus, related to the Orthopoxvirus genus. The 2022–2023 outbreak, driven by clade IIb, alongside ongoing outbreaks of clades Ia and Ib in Africa, highlighted mpox as a significant publ...

Open access Research Article 10.9734/jammr/2025/v37i105957